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Abstract
Introduction: A novel system that combines a compact mobile instrument and
Internet communications is presented in this paper for remote evaluation of tremors.
The system presents a high potential application in Parkinson’s disease and connects
to the Internet through a TCP/IP protocol. Tremor transduction is carried out by
accelerometers, and the data processing, presentation and storage were obtained by
a virtual instrument. The system supplies the peak frequency (fp), the amplitude (Afp)
and power in this frequency (Pfp), the total power (Ptot), and the power in low
(1-4 Hz) and high (4-7 Hz) frequencies (Plf and Phf, respectively).
Methods: The ability of the proposed system to detect abnormal tremors was
initially demonstrated by a fatigue study in normal subjects. In close agreement with
physiological fundamentals, the presence of fatigue increased fp, Afp, Pfp and Pt
(p < 0.05), while the removal of fatigue reduced all the mentioned parameters (p <
0.05). The system was also evaluated in a preliminary in vivo test in parkinsonian
patients. Afp, Pfp, Ptot, Plf and Phf were the most accurate parameters in the
detection of the adverse effects of this disease (Se = 100%, Sp = 100%), followed by
fp (Se = 100%, Sp = 80%). Tests for Internet transmission that realistically simulated
clinical conditions revealed adequate acquisition and analysis of tremor signals and
also revealed that the user could adequately receive medical recommendations.
Conclusions: The proposed system can be used in a wide spectrum of telemedicine
scenarios, enabling the home evaluation of tremor occurrence under specific medical
treatments and contributing to reduce the costs of the assistance offered to these
patients.
Introduction
Parkinson’s disease (PD) is the most prevalent movement disorder, leading to symp-
toms including tremor, rigidity and bradykinesia [1]. According to the World Health
Organization, in 2004 approximately 5.2 million people in the world presented this dis-
ease [2]. As a result of population growth and the increase in life expectancy, the num-
ber of people affected by PD will likely double in the next 25 years [3].
Rest tremor is the most common and easily recognized symptom of PD [4]. How-
ever, measuring the impact of therapeutic interventions on tremor features in PD
poses a challenge because the severity of tremors may vary strongly during the day.
Another important point is that most clinical rating scales are subjective. Additionally,
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any medium, provided the original work is properly cited.the self-assessment of symptom severity by patients is not very reliable [5]. To over-
come these shortcomings, objective assessment instruments have recently been devel-
oped. Es`kov et al. [6] described a research system for human micro movements that
can be used to measure tremor. Hoff et al. [7] used a commercial portable multichan-
nel recorder for quantitative continuous 24-hour monitoring of tremor while the
patient is at home. Yang et al. [8] presented a portable device for the long-term mea-
surement and recording of tremor in which these signals are stored in a compact flash
memory card. More recently, Salarian et al. [9] developed an ambulatory system for
quantification of tremor and bradykinesia in patients with PD that is based on minia-
ture gyroscopes, while Engin [10] described an ambulatory instrument based on two
axis acceleration sensors and Slack and Xianghong [11] presented a methodology for
measuring the hand tremor of surgeons.
Due to the dramatic progress and concomitant decrease in the costs of electronics
and telematics, many individuals have gained access to efficient communication solu-
tions [12]. This allows for the possibility of growth in a specific telemedicine area, that
of telemonitoring outside the hospital, i.e., at a patient’sh o m eo rv e r yc l o s et oi t
[12-14]. Portable electronic monitoring equipment has been shown to assist in the
home monitoring of blood glucose [13], congestive heart failure [14], cardiovascular
function [15] and geriatric patients who have a risk of falling [16].
Given the high relevance of telemonitoring PD patients, this problem has attracted a
lot of attention recently, as can be observed in a recent conference [17-19] and cur-
rently ahead of print papers [20,21]. Patel et al. [22] used accelerometers to evaluate
motor complications in persons with PD, and to predict the clinicians’ estimates of dis-
ease symptom severity. Other signals have also been used in PD telemonitoring. Little
et al. [23] assessed the practical value of discriminating healthy people from people
with PD by detecting dysphonia. Tsanas et al. [24] proposed the use of speech tests in
the evaluation of PD progression. Goetz et al. [25] tested the feasibility of a telemoni-
toring testing device in early-stage, unmedicated PD patients.
In this paper, we developed a wireless tremor monitoring system that integrates cur-
rent personal digital assistant (PDA) and wireless communication technology, with a
high potential to contribute in home monitoring of patients with Parkinson’s disease.
A system for tremor recording and analysis is useful for at least two different user
groups. Firstly, non-technical biomedical professionals who want to analyze tremor
records in standardized daily clinical procedures, and secondly, users who work in dif-
ferent fields of tremor research. For the first group, the system should provide the pos-
sibility of displaying the results of a tremor analysis by means of a user-friendly front
panel, whereas researchers usually need an open architecture with the flexibility to
modify configurations and parameters.
Methods
System architecture
The general architecture of the instrument is reported in Figure 1. The telemedicine
system consists mainly of two parts: 1) the mobile unit, which is set up around the
patient to acquire the patient’s tremor data and to receive medical recommendations,
and 2) the hospital unit, which enables the medical staff to telemonitor the patient’s
condition and to send medical recommendations.
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or a mobile laptop. The bidirectional transmission of data between the mobile unit and
the hospital unit was implemented by the TCP/IP architecture. If the central station PC
is in the same room as the mobile unit the communication can be accomplished simply
by connecting a USB cable from the central station PC to the mobile unit (PDA).
Hardware
A detailed block diagram of the transducer and signal processing stages is shown in
Figure 2.
The transducer used was a micromachined three axis accelerometer ADXL330 (Ana-
log Devices), which is a small (4 mm × 4 mm × 1,45 mm) low power device that oper-
ates in a full-scale range of 3 g. Operating at 3.6 V, the sensitivity is 300 mV/g, with a
nonlinearity of ±0.3% of full-scale and a bandwidth of 550 Hz.
The power source of the instrument was implemented using a rechargeable ion-
lithium battery (KLIC-5001, Kodak Company) with a nominal tension of 3.6 V, current
capacity of 1050 mAh and weight of 47 grams. A DC/DC converter (MAX680 -
Maxim Integrated Products, Semiconducting Dallas) was used to get an adequate vol-
tage supply to the circuits. The battery was initially adapted to the MAX680 to obtain
symmetrical voltages of ± 10 V. The -10 V, in turn, is applied to a low power voltage
Figure 1 Simplified block diagram of the telemedicine instrument for home monitoring of tremor.
Figure 2 block diagram describing the transducer and signal processing stages HPF, high-pass
filter, A, amplification, LPF, low-pass filter, ISO, isolator.
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Page 3 of 17regulator (MAX664) to be converted into -5 V, while the 10 V is converted to 5 V by a
similar regulator (MAX666). The last IC cited includes a low battery detector that
operates by comparing the battery voltage with an internal reference. The output of
this comparator is an open drain field effect transistor, which can be damaged during
the connection of the instrument to the external data acquisition system. We used an
optocoupler in order to avoid this problem.Ap r e c i s i o nr e f e r e n c e( R E F1 9 3 ,A n a l o g
Devices) was used to provide a stable 3.6-V reference to the acceleration transducers.
The human tremor vibrations are separated from continuous gravity acceleration by
an analogue first-order high pass filter (0.3 Hz). Previous studies have shown that the
tremor frequency in PD patients occurs below 30 Hz [7,26,27]. Thus, the X,Y,Z accel-
eration signals are amplified and adapted to low-pass filters (Butterworth, 4th order)
with a cut-off frequency of 30 Hz used to eliminate external noises and the effect of
aliasing. In order to increase the autonomyo ft h es y s t e m ,a l lo ft h ea n a l o g u ep r o c e s -
sing circuits were implemented using operational amplifiers with very low power con-
sumption (OP 295, Analog Devices). With the aim of protecting the data acquisition
board, the X,Y,Z acceleration signals as well as the battery-monitoring signal were
maintained in a secure amplitude range by using limiter circuits constructed around
zener diodes of 4.7 V.
These signals were adapted to a Compact Flash data acquisition card (NI CF-6005,
National Instruments, Austin, Texas) with a resolution of 14 bits, four channels and a
maximum sampling frequency of 200 kHz.
Software
The system control programmes were developed in two environments: the PDA envir-
onment, based on the LabVIEW 8.2 PDA Module for Windows Mobile (National
Instruments, Austin, TX) and the PC environment using LabVIEW 8.2 (National
Instruments, Austin, TX). The graphical “G” programming used in LabVIEW™ allows
a synthesis in icons of subroutines or complex algorithms, which can be interfaced by
means of simple connections with other icons that compose a main programme. This
feature makes the modification or inclusion of new subroutines easier, allowing the
fast integration of new knowledge concerning the pathophysiologic mechanisms
involved in Parkinson’s disease without changing the structure of the main programme.
In order to make clinical applications easier for non-technical personnel, dedicated
user-friendly front panels were developed in the PDA environment. These interfaces
are shown in Figure 3.
The software is composed of three main modules. The first includes subroutines to
describe the characteristics of the patient and the results of the exam. The characteris-
tics of the procedure may also be saved for further analysis, allowing easy evaluation of
the evolution of medical treatments (Figure 3A). The second module performs acquisi-
tion of signals during the exam. The measurement of the three acceleration signals
was performed simultaneously with a sampling frequency of 196 Hz. These signals are
used to calculate the resultant acceleration vector, which is presented on the front
panel of the virtual instrument. The acquisition occur over 20 s (Figure 3B). This mod-
ule also includes routines that allow data transfer between the patients’s PDA (the ser-
ver) and the remote computer (the client). Also included in the software is a third
module that allows the user to receive medical recommendations from the hospital
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and easy adjustment of medical treatments.
The LabVIEW PDA environment presents all the necessary tools for elaboration of
the programmes to be used with the patient’s PDA (the server) and the remote compu-
ter (the client), in order to allow for data transfer using the Internet by means of a cel-
lular connection. Communication between the PDA and the cellular (Nokia N95) was
effected using the bluetooth protocol. Bluetooth is currently the most promising tech-
nology for wireless communication in an indoor environment. The advantage of Blue-
tooth compared to infrared technology is that the former does not require the sender
to be in the line of sight of the receiver, as long as they are within the communication
range, so the presence of an obstacle does not prevent communication, as opposed to
infrared technology. Moreover, Bluetooth technology implements other features related
to the security of communication, such as data encryption and user authentication,
which can be particularly convenient when managing sensitive information such as
clinical data. Another significant benefit for the patient is that medical recommenda-
tions obtained from the analysis of the results sent previously could also be sent. In
the PDA environment, the hardware platform used was a Palmtop iPAQ HP hx2490
with 520 MHz, 64 Mb of RAM and 192 Mb of ROM, with the operating system
Microsoft
® Windows Mobile
® 5.0.
In the PC environment, on the other hand, the hardware platform was constituted by
an Intel Core 2 Duo 2.2 GHz computer with 4 GB of RAM, a hard disk of 80 GB and
Microsoft Windows XP operating system. A user-friendly front panel was also devel-
oped to be used in the PC environment. This interface is shown in Figure 4. Initially,
the characteristics of the patient, of the exam and of the medical procedure are pre-
sented to the user (Figure 4A). The second module provides a graphical description of
the tremor signal against time (Figure 4B), allowing the user to detect artifactual events
such as speaking and inappropriate corporal movements by visual analysis.
The user may also perform a quantitative off-line analysis of the measured accelera-
tions. To this end, initially the average value of the vector sum is removed. Then, the
amplitude spectrum was estimated using the available fast Fourier transform (FFT)
 
Figure 3 Graphical user interfaces of the instrument in the PDAenvironment. The software allows for
the description of the characteristics of the patient and the results of the exam (A), and the data
acquisition provides signal presentation and transference of the data between the patients’sPDA, the server
and the remote computer (B). Medical recommendations may also be received by the patients (C).
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Figure 4 Graphical user interface of the instrument in the PC environment, which allows the user
to observe the characteristics of the patient and the exam (A), a quantitative off-line analysis of
the tremor signal (B), and a return of medical recommendations for the patient (C).
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1960 points), which resulted in a spectral resolution of 0.1 Hz [10]. A fifty percent
overlap was used in order to increase the number of independent data blocks and
reduce random errors. Data blocks were multiplied by a Hanning window and then
processed by Fourier analysis. The values from each 10-second period (three blocks)
were averaged, and the result of the test was calculated as the mean of these measure-
ments. These points describe acceleration as a function of frequency and are expressed
in units of g (Figure 4). Based on the mean spectrum, the program uses an algorithm
available in LabVIEW 8.2 that automatically searches for the frequency at which the
signal of highest intensity occurs (peak) and estimates the peak frequency (fp) and the
power around it (Pfp). The power is estimated considering three frequency lines before
the peak frequency line, the peak frequency line itself, and three frequency lines after
the peak (eq. 1).
Pfp P(f)
fp-0.3Hz
fp 0.3Hz
=
+
∑ (1)
Peak amplitude (Ap) was also obtained using a built-in LabVIEW algorithm. As the
oscillations in pathological tremors are only approximately sinusoidal [28], the pro-
gramme also includes the estimate of the total power (Ptot). This parameter was
obtained by considering the power throughout the frequency range studied (eq. 2).
Ptot P(f)
0.3 Hz
30 Hz
= ∑ (2)
After the patient evaluation, based on the previously described parameters, the physi-
cian may also send medical recommendations back to the patient’s PDA using the
panel described in Figure 3C. This facility contributes to a fast and easy adjustment of
medical treatments.
Instrument access, data security, error handling protocols
For security reasons, algorithms for proper authorization use of the virtual instrument
were developed. For both the fixed and portable subsystems, all users are required to
enter a user name (login) and a password to access the system.
Great care was taken to ensure secure data transmission capability over public data
networks. Firstly, we chose Bluetooth technology to perform the data transmission
between the PDA and the telephone because Bluetooth protocols performs frequency
hopping over 79 channels, each one displaced by 1 MHz (in the Industrial Scientific
and Medical band, between 2.402-2.480 GHz), at 1600 hops per second. Bluetooth pro-
tocols also implement reliable and robust data encryption and user authentication
solutions. More specifically, we used Bluetooth version 1.2, class 2 (range of 10 m)
with transmission speed of 1 Mbit/s. Bluetooth security procedures are based on a
L2CAP (Logical Link Control and Adaptation Protocol) implementing translation of
data into secret code based on the SAFER (Secure And Fast Encryption Routine) and a
block cipher encryption algorithms. Therefore, eavesdroppers cannot read the contents
during data transmission. Data security and integrity are also guaranteed by pairing
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devices, and then the identity of the devices is cryptographically authenticated pre-
viously to starting communicate.
Data interchange in the Internet was performed using International Mobile Telecom-
munications-2000 (IMT-2000) standards, also known as 3G. We chose to use this
technology because of the enhanced cryptography methods used to implement confi-
dentiality and integrity algorithms. In addition to the data security cryptography used
in Bluetooth and IMT-200 standards, a custom encryption algorithm was also imple-
mented in our laboratory using the LabVIEW 8.2 environment. This algorithm allows
both mobile unit and hospital unit to perform additional encryption.
All built-in error handling routines available in LabVIEW 8.2 PDA Module were
used to ensure that data were completely transferred and without transmission arti-
facts. During data transmission, these routines could detect file errors before sending
it. In these cases, an error message is displayed to the user in order to correct the
error or to repeat the tremor measurement. If an error occurs during TCT-IP data
exchange, it is canceled and an error message describing the error displayed to the
user, allowing the starting of a new data exchange procedure.
When data are received, error handling protocols first check the number of bytes to
read. If the number of bytes is fewer than the requested number that arrives after the
maximum time expected to perform communication (25 s), a timeout error is reported
and data may not be used. The software automatically send a message to the patient
requesting the re-sending of the file and ensuring data integrity.
Laboratory In vivo tests in normal subjects during fatigue
The ability of the proposed system to detect human tremor was initially validated in a
simulated study in normal subjects. Thus, we performed a comparative analysis on the
results obtained in 10 normal subjects (28.6 ± 9.1 years, 72.5 ± 9.2 kg, 172.6 ± 7.6 cm,
6 male) in three conditions: (1) with the arm extended without load; (2) in a similar
way supporting a mass around 1.6 kg and (3) with the arm extended after the release
of the load. These manoeuvres are known to provoke tremor associated with muscular
fatigue [29,30]. In these evaluations, the transducers had been adapted to the right
wrist of the volunteers. The measures were made with the volunteers standing with
their right arm extended.
Laboratory In vivo tests in patients with Parkinson’s disease
The system was also validated by a comparative analysis between 10 normal subjects (28.5
± 8.5 years, 66.4 ± 12.7 kg, 170.4 ± 9.0 cm, 5 male) and 10 subjects with Parkinson’s dis-
e a s e( 6 9 . 8±7 . 1y e a r s ,6 9 . 4±1 2 . 0k g ,1 5 6 . 0±8 . 9c m ,3m a l e ) .I nt h i sc o m p a r i s o n ,t h e
transducers had been attached to an elastic strap and adapted to the wrist associated with
the arm that had first presented tremors due to Parkinson. The measures were made with
the individuals comfortably seated in a chair, with feet flat on the ground. The measured
arm was extended along the body, with the hand of the segment not assessed resting on
the respective leg (Figure 5). The exams began after a period of approximately one minute
of adaptation to the apparatus, and volunteers were asked to not wear bracelets, watches
or rings during the measurements.
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research Committee of the State University of Rio de Janeiro. Informed consent was
o b t a i n e df r o ma l lv o l u n t e e r sbefore inclusion in the study. The data are expressed as
means ± SD.
As can be seen in Table 1 in the Results section, tremor in PD patients usually
occurs at a frequency between 4 and 6 Hz, while in normal subjects fp is around 2 Hz.
In order to contribute to the diagnosis of tremor, this study also included the evalua-
tion of the powers in the cited frequency ranges (1-4 Hz, Plf, and 4-7 Hz; Phf). The
ability of the studied parameters to identify abnormal movements in Parkinson’s
patients was evaluated by means of receiver operating characteristic (ROC) analyses,
which were conducted using MedCalc 8.2.
Data from, Afp followed a normal distribution and therefore the standard t-test was
used. A non-parametric test (Mann-Whitney U Test) was applied for non-normal
Mobile unit 
Transducers 
Hospital unit 
Cell
phone 
Figure 5 Picture of the telemedicine instrument. The figure shows the typical positioning of the
volunteer during the exam, the PDA, the hospital unit, the mobile unit and the transducer positioning on
the patient’s wrist.
Table 1 Tremor parameters in normal subjects and in patients with Parkinson’s disease.
fp
(Hz)
Ap
(g)
Ppf
(mV
2)
Ptot
(mV
2)
Plf
(mV
2)
Phf
(mV
2)
Controls (n = 10) 2.6 ± 1.5 0.0021 ± 0.0011 0.003 ± 0.003 0.022 ± 0.0068 0.007 ± 0.003 0.006 ± 0.004
Parkinson (n = 10) 5.4 ± 1.5 0.091 ± 0.0791 6.7 ± 9.5 42.1 ± 48.1 9.2 ± 14.0 24.6 ± 25.8
p < 0.01 < 0.01 < 0.001 < 0.001 <0.001 <0.001
Sensitivity (%) 100 100 100 100 100 100
Specificity (%) 80 100 100 100 100 100
AUC 0.895 1 1 1 1 1
Values are presented as means ± SD. SD = standard deviation; fp = peak frequency; Ap = peak amplitude; Pfp power
around the peak frequency; Ptot = total power; Plf = power in low frequency; Phf = power in high frequency; AUC =
area under the receiver operating characteristic curve.
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software. A p value of less than 0.05 was considered as statistically significant.
Internet transmission tests
The first tests for Internet transmission were conducted in the laboratory by sending
information from the mobile unit to a bench top computer. Five tests were performed,
and the simulated results and recommendations were exchanged via the Internet.
For an initial proof of concept on remote monitoring and medical information
exchange, typical measurements were performed, realistically simulating clinical condi-
tions. To this end, tremor measurements were performed in normal subjects during
fatigue. These subjects were located in three private homes in Rio de Janeiro, Brazil,
and this information was sent to our laboratory in Rio de Janeiro. Simulated medical
recommendations were also sent back to these subjects.
We assessed the overall network speed between the PDA and the PC. The test was
conducted transmitting typical files over the Internet (tremor exams: approximately
150 kB; recommendations: approximately 1.0 kB). The transmission speed was evalu-
ated once an hour, for a period between 9:00 and 18:00.
Results
A prototype of the overall system has been designed and implemented. The photo-
graph in Figure 5 depicts the developed system.
The mobile unit, which includes the tremor signal acquisition module and a wireless
PDA, is compact and lightweight (600 g). The current consumption of the module is
2.5 mA. Considering this consumption, the battery used (1050 mAh) and a mean mea-
surement time of 5 minutes, the signal acquisition module has autonomy of approxi-
mately 420 measurements. The Pocket PC, on the other hand, can run under its own
power for at least 4.3 hours. Considering the same mean measurement time, the PDA
has autonomy of 51 measurements.
Laboratory In vivo tests in normal subjects during fatigue
A representative example of the typical results obtained in these studies is presented in
Figure 6. Figure 7A,C,E and 6G present results comparing basal tremor parameter
values before fatigue, during fatigue events, and after fatigue in each of the studied
subjects. Mean values of fp and Ap (Figure 7B and 7D) presented highly significant
increases during fatigue (p < 0.001 and p < 0.01, respectively). Mean values of Pfp
(Figure 7F) and Ptot (Figure 7H) also presented significant increases during fatigue
(p < 0.05 and p < 0.01, respectively).
T h er e m o v a lo ft h em a s sa n dt h ec o n s e q u e n tf atigue remission caused a significant
decrease in fp and Ap (p < 0.001 and p < 0.01, respectively), which became similar to the
values observed before fatigue (Figure 7B an d7 D ;p=n s ) .O na v e r a g e ,P f p( F i g u r e7 F )
and Ptot (Figure 7H) also presented significant decreases after removal of the mass (p <
0.05 and p < 0.01, respectively), returning to values similar to those detected before
fatigue (p = ns).
Laboratory In vivo tests in patients with Parkinson’s disease
Figure 8 shows typical results describing the influence of Parkinson’sd i s e a s eo nt h e
tremor signal in the time (A) and frequency (B) domains.
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The mean values of fp and Ap presented highly significant increases in Parkinson’s disease
patients (p < 0.01 and p < 0.01, respectively). The Ppf, Ptot, Plf and Phf values were higher
in Parkinsonian patients and presented the most significant differences among all
parameters studied (p < 0.001).
The amplitude in the peak frequency, Ppf, Ptot, Plf and Phf achieved perfect accuracy
(AUC = 1) in the detection of tremors in patients with Parkinson’s disease, with a sen-
sitivity of 100% and a specificity of 100%.
Internet transmission tests
In the five initial Internet communication tests conducted in the laboratory, there were
no errors in the comparison of the files saved on the PDA and those sent via the Inter-
net. In the second tests, involving three simulated exams in normal subjects located in
A
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Figure 6 Representative examples of the typical results obtained in normal subjects before (A,B),
during (C,D) and after fatigue (E,F).
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the client computer, perform the spectral analysis on the tremor signals and obtain tre-
mor parameters without errors. On the other hand, the remote PDA user could also
adequately receive simulated medical recommendations.
The network speed varied with time (mean ± SD = 3.6 ± 1.6 kBps; maximum = 6.4 kBps;
minimum = 0.9 kBps). Therefore, the PC receives tremor data sent from the PDA in a
mean time of 41.6 s and a maximum time of 2.8 min. Recommendation files, on the other
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Figure 7 Individual values (A,C,E,G) and mean values (B,D,F,H) of the tremor parameters before
fatigue, during fatigue events, and values obtained after fatigue (E).
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Page 12 of 17hand, may be sent from the PC and received in the PDA in a mean time of 0.3 s and a
maximum time of 1.1 s.
Discussion
It is expected that telemedicine, and especially home telecare, will gain increasing dif-
fusion in the coming years [31]. In this context, Lin et al. [32] recently developed a
wireless PDA-based system to telemonitor a patient’sv i t a ls i g n sc o n t i n u o u s l yd u r i n g
intrahospital transport.
We developed a medical instrument for remote evaluation of tremor, with high potential
use in home monitoring of patients with Parkinson’s disease. Indeed, the treatment of sev-
eral disorders can benefit from home tremor monitoring solutions, such as multiple
sclerosis, stroke, traumatic brain injury and a number of neurodegenerative diseases that
damage or destroy parts of the brainstem or the cerebellum. Measurements of tremor at
home without hospitalisation could reduce costs, enable follow-up of tremor results after
specific medical treatments and allow for observation of the effects of environmental and
behavioural factors such as physical activity, smoking and diet on tremor results.
While home monitoring enables longitudinal studies, it also places stringent con-
straints on the system: cost, size, unobtrusiveness, ease of use, and maintenance of sig-
nal quality. The mobile system developed in the present work is simple to use and
does not hinder the patients. In fact, the mobile unit is lightweight and easy to carry.
This subsystem may even be worn attached to a belt around the waist. The power
autonomy allows more than 50 exams. During tremor measurements, the patient
briefly interrupts their daily activities, sits on a chair and the data acquisition unit and
the PDA are placed on a table. The system has a user-friendly interface that records
patient information, collects and displays tremor biosignals and supports wireless
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Figure 8 Examples of results obtained with the proposed system for the evaluation of the human
tremor. Time and amplitude spectrum of a normal individual (A,B) and similar signals from a patient with
Parkinson’s disease (C,D). Note the difference in the amplitude spectrum scales.
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Page 13 of 17communication. The instrument does not present hardware-based controls, which
greatly simplifies its use by nontechnical personnel. On the other hand, the PC unit
has an easy-to-use interface that is used to input patient information, display tremor
biosignals and to launch an analysis panel. When needed, the FFT analysis can be per-
formed on the tremor signal by clicking a button. In addition, several parameters can
be calculated to describe the tremor signal characteristics.
Laboratory In vivo tests in normal subjects during fatigue
Initially, the proposed system was validated in a simulated study under controlled con-
ditions in normal subjects evaluating its ability to detect tremor under conditions of
fatigue. In the absence of weight (Figures 5 and 6), a tremor of low amplitude, power,
and frequency around 2.0 Hz was observed. In agreement with the physiology involved
[29], the studied parameters fp, Afp, Pfp and Pt increased in all of the studied volun-
teers during the fatigue process (Figure 7). This resulted in significant increases in the
mean values of the cited parameters. Subsequent removal of the weight resulted in the
reduction of all the studied parameters. It is interesting to note that after removal of
t h ew e i g h ta n dt h ee n do ff a t i g u ee v e n t s ,i ti sp o s s i b l et oo b s e r v eas i g n i f i c a n tr e d u c -
tion of the tremor parameters and a return to the initial condition before fatigue.
These results are consistent with physiology fundamentals [29] as well as with pre-
vious results obtained with strain gauge measurements [30] and clearly describe the
increased tremor frequency and amplitude associated with the process of muscular
fatigue. This provides substantial evidence that the proposed system can be useful in
the study of physiological tremor in normal individuals.
Laboratory In vivo tests in patients with Parkinson’s disease
In the second experimental validation study, the results obtained in 10 parkinsonian
subjects were compared with 10 control subjects. In line with previous results [10,28],
we found higher tremor frequencies, amplitudes and powers in patients with Parkin-
son’s disease (Figure 8, Table 1). These results are also consistent with the findings of
Hashemi et al. [33] and a recent clinical review that pointed out that parkinsonian tre-
mor occurs at a frequency between 4 and 6 Hz [4].
Using the studied parameters, it was possible to clearly differentiate the abnormal
tremor events in Parkinson’s patients. The performance of the studied indices was
evaluated by means of ROC curves [34,35]. Analysis of ROC curves is performed by
plotting sensitivity versus 1-specificity for each possible cut-off level. This way, the lar-
ger the area under the curve (AUC), the more valid the diagnostic test. According to
the literature, ROC curves with AUCs between 0.50 and 0.70 indicate low diagnostic
accuracy, AUCs between 0.70 and 0.90 indicate moderate accuracy, and AUCs between
0.90 and 1.00 indicate high accuracy. An AUC > 0.80 is usually considered adequate
for clinical use [34,36]. Thus, fp reached acceptable values for clinical use, identifying
patients with abnormal tremor with a sensitivity of 100% and a specificity of 80%
(Table 1). Higher accuracies were obtained when the Afp, Ppf, Ptot, Plf and Phf were
considered, which allowed a perfect identification of tremor in normal subjects and in
patients with Parkinson’s disease (AUC = 1). Thus, these parameters may be useful in
the clinical detection of abnormal tremor in parkinsonian patients. These results also
confirmed that this system could be a convenient alternative to ambulatory exams.
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Tremor recording by the patient at home may present artifacts associated with accel-
eration signals due to speaking or other movements of the patient during tremor
exams. In our system these events can be easily detected by the patient by visual analy-
sis of the tremor signal, which is displayed on the screen after the measurement. Even
if the patient sent measurements with errors, these errors may be easily detected in
hospital unit since the developed software allows biomedical professionals to obtain a
detailed visual description of possible artefactual events in the time and frequency
domains. In the presence of these events, patients can be promptly advised and asked
to perform and send a new tremor exam. The possible transmission of duplicate files
by the patient is another reason to discard tremor measurements in the central hospi-
tal unit. To prevent this error, a routine in LabVIEW 8.2 was developed in order to
compare the received file with others previously sent by the same patient. In the event
of sending a duplicate file, the patient is automatically notified by an automatic mes-
sage explaining what happened and asking permission to send the file.
System architecture and transmission tests
An important aspect of the system, as it is designed to be used by non-technical bio-
medical professionals, is that users generally expressed positive comments about ease
of use of the instrument and in configuring the proper settings. Laboratory communi-
cation sessions proved to be robust, and were performed correctly in all of the tests.
Communications between the mobile unit and the central unit were designed to be
bidirectional. All laboratory and remote tests were conducted using a commercial
phone network. Tests realistically simulating clinical use showed that it was possible to
send tremor data from the mobile unit and also to receive simulated medical recom-
mendations without any errors. Although the network speed varied with time (mean ±
SD = 3.6 ± 1.6 kBps), resulting in a maximum transmission time of 2.8 min, in prac-
tice, the observed velocities may be considered adequate for the desired application.
Limitations of the study
T h e r ea r et h r e ep o t e n t i a ll i m i t a t i o n si nt h ep r e s e n ts t u d y .T h ef i r s to n ei ss e e ni n
Table 1, where the standard deviations of Ppf, Ptot are almost as large as the mean
values. This may induce the reader to think that these parameters are difficult to be
trusted. Since the ability of the cited parameters to detect the differences between nor-
mal and patients was demonstrated by the high values of sensibility, specificity and
AUC (table 1), these high standard deviations are not a problem in the present study.
The second potential limitation concerns the clinical validation of the proposed sys-
tem in home monitoring of abnormal tremor in PD patients. The present work is dedi-
cated to describe a new instrument and to a feasibility study showing that the
instrument is useful in tremor measurements, and can be used in remote evaluations.
It is not a demonstration that it will be clinically successful in monitoring Parkinson’s
patients. This would require a different kind of study, which is clearly beyond the
scope of the present paper.
Finally, the data sample of only 10 patients with PD is limited. A larger sample of
subjects would be necessary to draw more robust conclusions.
Barroso et al. BioMedical Engineering OnLine 2011, 10:14
http://www.biomedical-engineering-online.com/content/10/1/14
Page 15 of 17Conclusion
A novel system for tremor evaluation, with potential use in home monitoring of sub-
jects with Parkinson’s disease, was developed in the current study. Using this instru-
ment, the acquisition and analysis of tremor signals can be performed remotely
through the Internet. On the other hand, the user could also receive medical recom-
mendations. The system is small enough to be easily transported.
The ability of the system to detect abnormal tremor was initially validated by a fati-
gue study in normal subjects and then in a preliminary in vivo test in parkinsonian
patients. The proposed system may be useful in a wide spectrum of telemedicine sce-
narios, possibly enabling follow-up of tremor under specific medical treatments and
reducing the cost of assistance offered to these patients.
Based on these promising results, future work includes a clinical trial in which we
will perform a follow up in well-defined groups of Parkinson’s disease patients in order
to evaluate the clinical contribution of the home monitoring approach in improving
the patient’s outcomes.
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